Insight Molecular Diagnostics, Inc. (IMDX)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Insight Molecular Diagnostics Market Cap : 81.23M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 81.23M |
| November 05, 2026 | 80.25M |
| November 04, 2026 | 86.45M |
| November 03, 2026 | 89.39M |
| November 02, 2026 | 93.30M |
| October 30, 2026 | 96.56M |
| October 29, 2026 | 103.74M |
| October 28, 2026 | 103.74M |
| October 27, 2026 | 103.09M |
| October 26, 2026 | 97.87M |
| October 23, 2026 | 92.32M |
| October 22, 2026 | 92.65M |
| October 21, 2026 | 98.52M |
| October 20, 2026 | 98.85M |
| October 19, 2026 | 94.28M |
| October 16, 2026 | 98.19M |
| October 15, 2026 | 99.83M |
| October 14, 2026 | 91.02M |
| October 13, 2026 | 97.54M |
| October 12, 2026 | 103.41M |
| October 09, 2026 | 109.94M |
| October 08, 2026 | 107.00M |
| October 07, 2026 | 112.88M |
| October 06, 2026 | 110.27M |
| October 05, 2026 | 119.73M |
| Date | Value |
|---|---|
| October 02, 2026 | 112.22M |
| October 01, 2026 | 113.20M |
| September 30, 2026 | 117.12M |
| September 29, 2026 | 110.27M |
| September 28, 2026 | 103.74M |
| September 25, 2026 | 127.88M |
| September 24, 2026 | 128.86M |
| September 23, 2026 | 127.56M |
| September 22, 2026 | 135.06M |
| September 21, 2026 | 130.82M |
| September 18, 2026 | 130.49M |
| September 17, 2026 | 128.86M |
| September 16, 2026 | 116.79M |
| September 15, 2026 | 131.14M |
| September 14, 2026 | 131.14M |
| September 11, 2026 | 137.02M |
| September 10, 2026 | 129.84M |
| September 09, 2026 | 133.75M |
| September 08, 2026 | 139.30M |
| September 04, 2026 | 134.73M |
| September 03, 2026 | 134.41M |
| September 02, 2026 | 130.82M |
| September 01, 2026 | 125.27M |
| August 31, 2026 | 127.88M |
| August 28, 2026 | 134.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 95.83M |
| Agenus, Inc. | 304.70M |
| Amgen, Inc. | 249.04B |
| Anika Therapeutics, Inc. | 194.72M |
| BioCryst Pharmaceuticals, Inc. | 1.970B |
Market Cap Related Metrics
| PS Ratio | 50.46 |
| Price | 2.49 |
| Earnings Yield | -59.65% |